346 related articles for article (PubMed ID: 18630736)
21. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
Davis MA; Hanash S
Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
[TBL] [Abstract][Full Text] [Related]
22. Industrialized MS-based proteomics in the search for circulating biomarkers.
Migneault I; Hunter JM
Bioanalysis; 2009 Sep; 1(6):1149-63. PubMed ID: 21083081
[TBL] [Abstract][Full Text] [Related]
23. Urinary proteomics--a tool for biomarker discovery.
Pejcic M; Stojnev S; Stefanovic V
Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
[TBL] [Abstract][Full Text] [Related]
24. Fractionation of the human plasma proteome for monoclonal antibody proteomics-based biomarker discovery.
Kovács A; Sperling E; Lázár J; Balogh A; Kádas J; Szekrényes A; Takács L; Kurucz I; Guttman A
Electrophoresis; 2011 Aug; 32(15):1916-25. PubMed ID: 21732557
[TBL] [Abstract][Full Text] [Related]
25. Proteomic biomarker discovery: it's more than just mass spectrometry.
Blonder J; Issaq HJ; Veenstra TD
Electrophoresis; 2011 Jun; 32(13):1541-8. PubMed ID: 21557261
[TBL] [Abstract][Full Text] [Related]
26. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
Whiteley GR; Colantonio S; Sacconi A; Saul RG
Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
[TBL] [Abstract][Full Text] [Related]
27. Model-based discovery of circulating biomarkers.
Vogelsang MS; Kani K; Katz JE; Mallick P
Methods Mol Biol; 2011; 728():87-107. PubMed ID: 21468942
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins.
Desrosiers RR; Beaulieu E; Buchanan M; Béliveau R
Cell Biochem Biophys; 2007; 49(3):182-95. PubMed ID: 17952643
[TBL] [Abstract][Full Text] [Related]
29. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.
Hoffman SA; Joo WA; Echan LA; Speicher DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):43-52. PubMed ID: 17140865
[TBL] [Abstract][Full Text] [Related]
30. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles.
Smalley DM; Root KE; Cho H; Ross MM; Ley K
Thromb Haemost; 2007 Jan; 97(1):67-80. PubMed ID: 17200773
[TBL] [Abstract][Full Text] [Related]
31. Label-free mass spectrometry-based protein quantification technologies in proteomic analysis.
Wang M; You J; Bemis KG; Tegeler TJ; Brown DP
Brief Funct Genomic Proteomic; 2008 Sep; 7(5):329-39. PubMed ID: 18579615
[TBL] [Abstract][Full Text] [Related]
32. Targeted proteomics in biomarker validation: detection and quantification of proteins using a multi-dimensional peptide separation strategy.
Immler D; Greven S; Reinemer P
Proteomics; 2006 May; 6(10):2947-58. PubMed ID: 16619308
[TBL] [Abstract][Full Text] [Related]
33. How shall we use the proteomics toolbox for biomarker discovery?
Lescuyer P; Hochstrasser D; Rabilloud T
J Proteome Res; 2007 Sep; 6(9):3371-6. PubMed ID: 17655344
[TBL] [Abstract][Full Text] [Related]
34. Free-flow electrophoresis system for plasma proteomic applications.
Wildgruber R; Yi J; Nissum M; Eckerskorn C; Weber G
Methods Mol Biol; 2008; 424():287-300. PubMed ID: 18369870
[TBL] [Abstract][Full Text] [Related]
35. Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites.
Ossola R; Schiess R; Picotti P; Rinner O; Reiter L; Aebersold R
Methods Mol Biol; 2011; 728():179-94. PubMed ID: 21468948
[TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis of human plasma and blood cells in nutritional studies: development of biomarkers to aid disease prevention.
de Roos B
Expert Rev Proteomics; 2008 Dec; 5(6):819-26. PubMed ID: 19086861
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics challenges in the proteomic analysis of human plasma.
Foster JM; Martens L
Methods Mol Biol; 2011; 728():333-47. PubMed ID: 21468959
[TBL] [Abstract][Full Text] [Related]
38. Mass spectrometry is only one piece of the puzzle in clinical proteomics.
McGuire JN; Overgaard J; Pociot F
Brief Funct Genomic Proteomic; 2008 Jan; 7(1):74-83. PubMed ID: 18308835
[TBL] [Abstract][Full Text] [Related]
39. The amplified peptidome: the new treasure chest of candidate biomarkers.
Geho DH; Liotta LA; Petricoin EF; Zhao W; Araujo RP
Curr Opin Chem Biol; 2006 Feb; 10(1):50-5. PubMed ID: 16418009
[TBL] [Abstract][Full Text] [Related]
40. Processing and classification of protein mass spectra.
Hilario M; Kalousis A; Pellegrini C; Müller M
Mass Spectrom Rev; 2006; 25(3):409-49. PubMed ID: 16463283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
